Composition
- Active ingredients
- UBROGEPANT 50MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- UBROGEPANT 50MG · TabletThis page
- UBROGEPANT 100MG · TabletANDA219088-001 · Tentative approval
- UBROGEPANT 100MG · TabletANDA218662-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA219088.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ubrogepant
- Dosage form
- Tablet
- Applicant
- Aurobindo Pharma Limited
- Status
- Tentative approval
- FDA approval
- 28 May 2025
- Application
- ANDA219088-002